Glanza Biotech Private Limited - Company Profile

It is a trading private limited company based in Noida, Uttar Pradesh, India, established in 2011.
2011 Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Glanza Biotech Private Limited

Glanza Biotech Private Limited, a active private limited company, was established on 10 September 2011 in Noida, Uttar Pradesh, India. Engaging in retail trading within the trade sector, it holds CIN: U74120UP2011PTC046547. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Priti Singh Rathor (Director), Sukriti Singh (Director), Vineet Kumar Singh (Director). Past directors included Kamlesh Singh, Ram Singh, Anita Singh. Its latest AGM occurred on 15 September 2019, with the balance sheet filed on 31 March 2019. It is based at T-34 Sec 11, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120UP2011PTC046547

  • Registration Number

    046547

  • Incorporation Date

    10 September 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 5 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Glanza Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Glanza Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Glanza Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Priti Singh Rathor Director 21 Dec 2016 Current
Sukriti Singh Director 25 Jun 2013 Current
Vineet Kumar Singh Director 25 Jun 2013 Current
Anita Singh Director 10 Sep 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Jun 2013 Past
Pramod Abcsdd Director 12 Jul 2013 Past
Pramod Abcsdd Director 25 Jun 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glanza Biotech.

Glanza Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Glanza Biotech revenue growth over time
Glanza Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glanza Biotech?

In 2017, Glanza Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Glanza Biotech?

Unlock and access historical data on people associated with Glanza Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glanza Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glanza Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glanza Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Glanza Biotech Private Limited last Annual general meeting of members was held on 15 Sep 2019 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Glanza Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Kanpur. was documented.

  • Director Appointment

    Progress on Priti Singh Rathor was appointed as a Director was appointed as a Director on 21 Dec 2016 & has been associated with this company since 9 years 1 month . was documented.

  • Director Appointment

    The activity Sukriti Singh was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 12 years 7 months . was completed.

  • Director Appointment

    The activity Vineet Kumar Singh was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 12 years 7 months . was completed.

  • Director Appointment

    The activity Anita Singh was appointed as a Director was appointed as a Director on 10 Sep 2011 & has been associated with this company since 14 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Glanza Biotech Private Limited?

The CIN of Glanza Biotech Private Limited is U74120UP2011PTC046547.

Where is Glanza Biotech Private Limited headquartered?

Glanza Biotech Private Limited is headquartered at T-34 Sec 11, Noida, Uttar Pradesh, 201301.

When was Glanza Biotech Private Limited incorporated?

Glanza Biotech Private Limited was incorporated on 10 September 2011.

Who are the current directors of Glanza Biotech Private Limited?

The current directors of Glanza Biotech Private Limited are

What is the primary industry of Glanza Biotech Private Limited?

The primary industry of Glanza Biotech Private Limited is Trade.

Is Glanza Biotech Private Limited a listed company?

Glanza Biotech Private Limited is unlisted.

What is the capital structure of Glanza Biotech Private Limited?

The authorized capital of Glanza Biotech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Glanza Biotech Private Limited?

The compliance status of Glanza Biotech Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available